在儿童无控喘中血清环素水平的变化 (DADO第二阶段研究)
Alicia Habernau Mena1,2, Maria Angela Gonzalo Garijo3, Victoria Del Pozo Abejón4
1Department of Allergology, Hospital de Mérida, Badajoz, Spain.
Allergologia et immunopathologia
|January 9, 2025
概括
在经过12个月的优化管理后,患有非控制性喘的儿童中,静素水平显著下降,这表明其作为控制喘的生物标志物的潜力. 这一发现突显了儿童患者喘管理的改善.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 生物标志物发现发现
背景情况:
- 喘是儿童常见的慢性炎症性呼吸道疾病,但缺乏特定的生物标志物.
- 确定可靠的生物标志物对于监测儿童喘疾病活动和治疗疗效至关重要.
研究的目的:
- 在经过12个月的优化治疗后,研究患有非控制性喘的儿童血清静素水平的变化.
- 评估皮奥斯水平与喘症状,肺功能和生活质量改善之间的相关性.
主要方法:
- 一项前性观察性研究,涉及5至14岁患有非控制性喘的儿童.
- 评估肺功能,喘控制测试 (ACT),儿科喘生活质量调查问卷 (PAQLQ),血液中氨基酸蛋白,IgE和血清静素在基线和12个月后.
- 与对照组比较质素水平.
主要成果:
- 在患有非控制性喘的儿童中,血清内素水平在12个月后显著下降,从901.48 ng/ml降至67.93 ng/ml (p<0.001).
- 对照组中的静素水平为56.12 ng/ml.
- 在治疗后观察到喘症状,肺功能 (FEV1),喘控制 (ACT) 和生活质量 (PAQLQ) 的改善.
结论:
- 在儿童有效的喘管理下,血清质素水平显著下降.
- 皮洛斯显示出作为监测儿童群体喘控制和治疗反应的生物标志物的潜力.
- 这项研究支持皮奥斯在评估喘管理策略有效性的实用性.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K